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Abstract
Dengue virus is an emerging infectious agent that infects an estimated 50–100 million people annually worldwide, yet
current diagnostic practices cannot detect an etiologic pathogen in ,40% of dengue-like illnesses. Metagenomic
approaches to pathogen detection, such as viral microarrays and deep sequencing, are promising tools to address emerging
and non-diagnosable disease challenges. In this study, we used the Virochip microarray and deep sequencing to
characterize the spectrum of viruses present in human sera from 123 Nicaraguan patients presenting with dengue-like
symptoms but testing negative for dengue virus. We utilized a barcoding strategy to simultaneously deep sequence
multiple serum specimens, generating on average over 1 million reads per sample. We then implemented a stepwise
bioinformatic filtering pipeline to remove the majority of human and low-quality sequences to improve the speed and
accuracy of subsequent unbiased database searches. By deep sequencing, we were able to detect virus sequence in 37%
(45/123) of previously negative cases. These included 13 cases with Human Herpesvirus 6 sequences. Other samples
contained sequences with similarity to sequences from viruses in the Herpesviridae, Flaviviridae, Circoviridae, Anelloviridae,
Asfarviridae, and Parvoviridae families. In some cases, the putative viral sequences were virtually identical to known viruses,
and in others they diverged, suggesting that they may derive from novel viruses. These results demonstrate the utility of
unbiased metagenomic approaches in the detection of known and divergent viruses in the study of tropical febrile illness.
Citation: Yozwiak NL, Skewes-Cox P, Stenglein MD, Balmaseda A, Harris E, et al. (2012) Virus Identification in Unknown Tropical Febrile Illness Cases Using Deep
Sequencing. PLoS Negl Trop Dis 6(2): e1485. doi:10.1371/journal.pntd.0001485
Editor: Rebeca Rico-Hesse, Texas Biomedical Research Institute, United States of America
Received June 9, 2011; Accepted December 7, 2011; Published February 7, 2012
Copyright:  2012 Yozwiak et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by grants from the Pacific Southwest Regional Center of Excellence (PSWRCE) (to JD and AB), as part of NIH grant U54-
AI65359 and a grant from the Pediatric Dengue Vaccine Initiative (#VE-1 to EH). JD is supported by the Howard Hughes Medical Institute, the Doris Duke
Foundation, and the Packard Foundation. PS-C is supported by a PhRMA Foundation Pre Doctoral Informatics Fellowship. MDS is supported by NIH grant
5T32HL007185-34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: joe@derisilab.ucsf.edu
. These authors contributed equally to this work.
Introduction
Viral infections pose a significant global health burden,
especially in the developing world where most infectious disease
deaths occur in children and are commonly due to preventable or
treatable agents. Effective diagnostic and surveillance tools are
crucial for reducing disability-adjusted-life-years (DALYs) due to
infectious agents and for bolstering elimination and treatment
programs [1]. Previously unrecognized and novel pathogens
continually emerge due to globalization, climate change, and
environmental encroachment, and pose important diagnostic
challenges [2,3].
Dengue virus (DENV) infection is the most common arthropod-
borne viral disease of humans, with an estimated 50–100 million
clinical infections occurring annually worldwide [4]. DENV
infection manifests clinically as dengue fever or the more severe
dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS)
[4]. The increased spread of dengue virus and its mosquito vectors
in many subtropical regions over the past several decades,
especially in Latin America and Asia [5], highlights the need for
additional methods of dengue virus surveillance. Diagnosing
dengue relies on detecting viral nucleic acid or antigens in the
blood or confirming the presence of anti-DENV IgM and IgG
antibodies and therefore traditionally depends on RT-PCR,
ELISA, and viral cell culture methods [5–7]. Dengue diagnostics
are of crucial importance due to its broad spectrum of clinical
presentations, global emergence and spread, unique disease
epidemiology, and possible clinical relation to other as-yet
unknown tropical febrile pathogens.
Traditional viral detection methods, such as serology, virus
isolation, and PCR, are optimized for the detection of known
agents [2]. However, novel and highly divergent viruses are not
easily detected by approaches that rely on a priori sequence,
antigen, or cell tropism knowledge. PCR-based assays that employ
degenerate primers may successfully target conserved regions
within related virus groups, but unlike bacteria, viruses lack
universally conserved genetic regions, such as ribosomal RNA,
that can be exploited to amplify all viruses [8].
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Metagenomic analysis enables more systemic detection of both
known and novel viral pathogens [9–12] and is approached
through a variety of microarray and sequencing strategies
[13,14]. The Virochip is a pan-viral microarray platform that
has been previously utilized in the detection and discovery of
viruses from both human and animal samples [15–19]. Deep
sequencing and shotgun sequencing of human clinical samples
has been used for viral detection [20–23], novel virus discovery
[24–27], and divergent virus genome recovery [28]. Viral
metagenomic approaches have also been employed as a
diagnostic supplement to pathogen detection as part of public
health monitoring systems [22], but have been limited to shotgun
sequencing of viral-enriched libraries and have yet to utilize deep
sequencing data. Currently available sequencing platforms can
generate millions to billions of sequencing reads per run, far
exceeding large-scale shotgun sequencing [13]. Deep sequencing
of clinical samples, in which hundreds of thousands to millions of
sequencing reads are generated per sample, can be incorporated
into stepwise virus detection pipelines [29]. Database searches
using Basic Local Alignment Search Tool (BLAST) and other
alignment tools [30] can be used to identify sequences in samples
that correspond to known and novel viruses, including those
present at low concentrations or deriving from viruses that may
be too divergent to be detected with PCR or microarray
methods. Deep sequencing represents an unbiased, highly
sensitive method for identifying viral nucleic acid in clinical
samples.
This study describes the use of the Virochip microarray and
deep sequencing for the direct viral diagnosis of serum from cases
of acute pediatric febrile illness in a tropical urban setting. Patient
clinical data and serum samples were collected between 2005 and
2009 as part of an ongoing pediatric dengue study in Managua,
Nicaragua [31]. Virochip and deep sequencing were performed on
positive control samples and on 123 dengue virus-negative serum
samples. Using these methods, viruses were detected in 45 of 123
(37%) previously negative samples. Sequences derived from known
and apparently divergent viruses. The viruses identified in some of
the cases are known to induce symptoms consistent with those
observed, though the definitive causative agent of these infections
remains to be determined.
Methods
Study Population
Acute serum samples were collected from suspected dengue
cases at the Hospital Infantil Manuel de Jesu´s Rivera (HIMJR), the
National Pediatric Reference Hospital in Managua, Nicaragua,
after undergoing informed consent or the informed consent
procedure. Patients were enrolled in the study if they presented
with fever or history of fever less than 7 days and one or more of
the following signs and symptoms: headache, arthralgia, myalgia,
retro-orbital pain, positive tourniquet test, petechiae, or signs of
bleeding. Patients with a defined diagnosis other than dengue, e.g.
pneumonia, were excluded. Suspected dengue cases were tested
for dengue virus (DENV) infection at the Centro Nacional de
Diagno´stico y Referencia (CNDR) of the Nicaraguan Ministry of
Health and were considered laboratory-confirmed if: 1) DENV
was isolated, 2) DENV RNA was detected by reverse transcrip-
tase-polymerase chain reaction (RT-PCR), 3) seroconversion was
observed by IgM capture enzyme-linked immunosorbent assay
(ELISA) of paired acute and convalescent sera, or 4) a $4-fold
increase in DENV-specific antibodies was demonstrated by
inhibition ELISA in paired acute and convalescent sera [32]. All
patients were aged 6 months to 14 years and presented between
August 2005 and January 2009.
Approximately one half of the suspected dengue cases testing
negative by all four dengue diagnostic assays were included in the
metagenomics analysis described here. 34 cases (pools 1–4, see
below) corresponded to the subset of patients who presented
within 4 days of symptom onset and who reported both fever or
history of fever and rash. 89 of the samples (pool 5) were selected
randomly from among the remaining samples. As positive
controls, seven samples (pool 5) that had been clinically diagnosed
as virus positive were included. The study protocol was reviewed
and approved by the Institutional Review Boards (IRB) of the
University of California, Berkeley, and of the Nicaraguan Ministry
of Health.
Metagenomic Library Preparation
Total nucleic acid from 140 ml of serum was extracted using the
QIAamp Viral RNA Isolation Kit (Qiagen), which co-purifies
RNA and DNA. End-tagged dsDNA libraries were created
essentially as previously described [28]. RNA was reverse
transcribed in reactions containing 16 reaction buffer, 5 mM
dithiothreitol, 1.25 mM dNTPs, 20 pmoles primer (59-CGC TCT
TCC GAT CTN NNN NN-39), 100 U Superscript III (Invitro-
gen), and ,20 ng template. Following reverse transcription,
Sequenase reaction buffer and 2 U of Sequenase DNA polymerase
(Affymetrix) were added to samples for second strand synthesis.
The Sequenase reactions were performed twice so that starting
DNA templates would be converted into end-tagged library
molecules. The resulting libraries were amplified by PCR using
primer 59-CGC TCT TCC GAT CT-39. PCRs contained 16
reaction buffer, 2 mM primer, 0.25 mM dNTPs, 2 U Taq DNA
polymerase, and 2 ml library template. Thermocycling conditions
were 95uC for 2 min; 25 cycles of 95uC for 30 sec, 40uC for
30 sec, and 72uC for 1 minute, with a final extension of 5 minutes.
These libraries were further processed for microarray hybridiza-
tion and deep sequencing as described below.
For microarray hybridization, a fraction of each library was
amplified by PCR as above but with a modified dNTP mixture
including 5-(3-aminoallyl)-dUTP (Ambion) in lieu of 75% of the
dTTP normally in the mixture. The resulting amino-allyl-
containing DNA was purified using a DNA Clean and
Concentrator-5 column (Zymo Research). The eluate was heat
Author Summary
Dengue virus infection is a global health concern, affecting
as many as 100 million people annually worldwide. A
critical first step to proper treatment and control of any
virus infection is a correct diagnosis. Traditional diagnostic
tests for viruses depend on amplification of conserved
portions of the viral genome, detection of the binding of
antibodies to viral proteins, or replication of the virus in
cell cultures. These methods have a major shortcoming:
they are unable to detect divergent or novel viruses for
which a priori sequence, serological, or cellular tropism
information is not known. In our study, we use two
approaches, microarrays and deep sequencing, to virus
identification that are less susceptible to such shortcom-
ings. We used these unbiased tools to search for viruses in
blood collected from Nicaraguan children with clinical
symptoms indicating dengue virus infection, but for whom
current dengue virus detection assays yielded negative
results. We were able to identify both known and
divergent viruses in about one third of previously negative
samples, demonstrating the utility of these approaches to
detect viruses in cases of unknown dengue-like illness.
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denatured at 95uC for 2 min, cooled briefly on ice, then
fluorescently labeled in reactions containing 100 mM sodium
bicarbonate pH 9, 10% DMSO, and 667 mM Cy3 mono NHS
ester (GE Healthcare) for 1 hour at 25uC. Labeled DNA was
purified using DNA-CC-5 columns and added to hybridization
reactions containing 36SSC, 25 mM HEPES pH 7.4, and 0.25%
SDS. Hybridization mixtures were heated at 95uC for 2 minutes,
applied to microarrays, and hybridized overnight at 65uC.
Following hybridization, arrays were washed twice in 0.576
SSC and 0.028% SDS and twice in 0.0576SSC, then scanned on
an Axon GenePix 4000B microarray scanner. Three analysis tools
were used to analyze Virochip data: E-predict [33], Z-score
analysis [34], and cluster analysis [35]. An array was deemed
positive for a particular virus if the virus was identified by at least
two of these methods. Virochip results were deposited in the NCBI
GEO database (GEO accession series: GSE28142).
For deep sequencing, the Illumina paired-end adapter sequences
were appended to library molecules using PCR, essentially as
previously described [28]. Library generation primers (Table S1)
were modified from adapter A and adapter B sequences (Illumina).
Samples were reverse transcribed and libraries were created and
amplified as described above for the Virochip. Library molecules of
approximately 300 bp were purified on a 4% native polyacrylamide
gel, ethanol precipitated, and PCR amplified for 17 additional
cycles using a 22-nt-long primer consisting of the 39-end of Illumina
adapter A (primer 2) and the full-length 61-bp Illumina adapter B
(primer 4) under the following conditions: 2 cycles of 94uC for 30 s,
40uC for 30 s, and 72uC for 1 min, followed by 15 cycles of 94uC for
30 s, 55uC for 30 s, and 72uC for 1 min. Amplicons generated with
the correct adapter topology (one end with adapter A and the other
with adapter B) were approximately 355 bp and were separated by
polyacrylamide gel electrophoresis from adapter A/A and adapter
B/B amplicons, which migrate differently (approximately 40 bp
smaller or larger than the expected size). An additional 10 cycles of
PCR were then performed using the full-length adapter sequences
as primers (primers 3 and 4). Libraries were validated by Sanger
sequencing before high throughput sequencing. Following valida-
tion, samples were combined into five pools for sequencing. For
pools one through four reverse transcription primers included a
three or four-nucleotide barcode sequence at the 39-end. For pool
five, barcodes were located internally in the adapter sequence. Each
pool was sequenced on one lane of a flowcell on the Illumina
Genome Analyzer II (pools 1–4) or HiSeq 2000 (pool 5). Pools’ 1–4
molecules were sequenced as 67 nucleotide paired ends, and pool 5
molecules as 97 nucleotide paired ends. Paired-end sequencing was
performed for several reasons: (1) to double the overall amount of
data generated, (2) to double the amount of sequence information
per molecule, and (3) to provide anchors from which additional
sequence could be recovered by subsequent PCR.
Virus Sequence Recovery
In some cases, PCR and Sanger sequencing was used to confirm
Virochip and deep sequencing calls and to recover additional
sequence. Primer sequences are listed in Table S1. PCR
conditions were: 95uC for 2 minutes, 35 cycles of 95uC for
30 seconds, 50–60uC for 30 seconds (primer dependent), 72uC for
1 minute, and 72uC for 2 minutes. PCR products were size-
selected on an agarose gel, purified with the Purelink gel extraction
kit (Invitrogen), cloned, and Sanger sequenced.
Virochip Sensitivity
Full-length poliovirus genomic RNA was transcribed from
MluI-linearized plasmid prib(+)XpA using T7 RNA polymerase as
previously described [36]. Poliovirus RNA was mixed with HeLa
total RNA in a dilution series ranging from 1022 to 1026
poliovirus gRNA per HeLa RNA. Randomly-primed dsDNA
libraries were prepared, hybridized to the Virochip, and analyzed
as described above.
Phylogenetic Analysis
Predicted circovirus-like replicase sequences were searched
against the NCBI non-redundant protein database (BLASTx, E
value 1022). Aligning sequences were retrieved and consolidated
using CD-HIT into a set of representative sequences [37] (CD-
HIT version 4.5.4; parameters: -c 0.7). These sequences were
aligned in Geneious [38] as a global alignment with free end gaps
and trimmed to the 47 amino acid overlap shared by the two
recovered sequences. A neighbor-joining tree was generated by
Geneious Tree Builder [38].
Deep Sequencing Bioinformatics
The initial FASTQ data from each pool’s lane were binned by
barcode. The barcode-split reads were trimmed of non-template
deriving and potentially error-prone sequence: a randomly
incorporated nucleotide (N), the barcode bases, and the sequence
corresponding to the random hexamer, leaving 55 (pools 1, 2, and
4), 54 (pool 3), or 90 (pool 5) bases per read. The lowest complexity
fraction was identified by sequences with LZW ratios (compressed
size/uncompressed size) less than 0.45 [39]. Reads were aligned to
the human genome (build hg18) first using BLAT [40] with the ‘‘–
fastMap’’ flag, and after filtering, the remaining reads were aligned
using BLAT without the flag. Paired reads for which at least one of
the reads in the pair had at least 80% identity to the database were
marked as human and removed from subsequent analyses. After
removal of reads identified as human by BLAT, remaining reads
were aligned and filtered by mapping to the human transcriptome
using nucleotide BLAST (BLASTn version 2.2.21, word size 30, E
value 1023). Remaining reads were next aligned to the human
genome using BLASTn (word size 30, E value 1023), filtered, and
again aligned to the human genome by BLASTn (word size 11, E
value 10). After all human filtering, we reanalyzed the distribution
of the complexity of reads and observed a relative enrichment of
reads with LZW ratios lower than 0.54 (pools1–4) or 0.48 (pool5;
different LZW ratio distributions are an inherent property of
different read lengths), and those reads were removed from further
analysis. To look for reads with viral homology, we searched the
non-redundant nucleotide database (nt) using BLASTn (word size
20, E value 1023). Reads that did not map to nt were aligned to
the non-redundant protein database (nr) using translated BLAST
(BLASTx, word size 4, E value 10).
Virus Sequence Detection
In order to make specific virus-positive calls, we implemented a
set of rules to minimize false positives while maintaining sensitivity.
In order to reduce the number of false positive sequences that may
share identity equally with both viral and non-viral genomes, we
restricted our analysis to those queries whose best alignments were
only to animal viral sequences. In a number of datasets, we
detected human klassevirus 1, a virus identified and studied in our
lab [26], human poliovirus, used in our Virochip sensitivity
experiments, sequences from mosquito densoviruses, also studied
in the lab, as well as Moloney murine leukemia virus (MMLV), the
polymerase of which was used in the sequence library preparation.
We believe these reads represent lab contaminants, and others
studies that prepared sequence libraries in the same location have
reported similar findings [41]. To account for these contaminants,
positive calls were only made on viruses for which there were more
supporting reads than there were reads to any known contami-
Sequencing Viruses in Tropical Dengue-like Illness
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nant. Finally, in order to avoid making calls based on potentially
spurious alignments, we considered only those viruses for which
there were at least 10 reads supporting their presence.
Results
Virochip Analysis
We initially screened the serum samples with the Virochip pan
viral detection microarray. This was done as a complement to the
deep sequencing analysis and in order to compare the sensitivity of
the two approaches. We included 7 blinded positive control
samples that had been previously diagnosed in the clinic as being
positive for DENV-2 (n = 4), DENV-1 (n = 1), or hepatitis A virus
(HAV; n = 2). The Virochip successfully identified the correct virus
in all of these positive controls, and in the case of the dengue virus
positive samples, the correct serotype as well (Table 1). We also
identified ten samples positive for torque teno virus (TTV).
We applied in vitro transcribed poliovirus RNA diluted into
HeLa cell total RNA to the Virochip as an additional positive
control to quantify Virochip sensitivity. Using the E-predict
analysis tool, the lowest detectable concentration of poliovirus was
1 viral RNA per 105 HeLa RNA molecules (approximately 10
polio gRNAs per cell equivalent of HeLa RNA; Figure S1).
Deep Sequencing Analysis
A total of 130 serum samples were deep sequenced, including 7
positive controls and 123 previously undiagnosed samples. We
performed deep sequencing on 34 of the serum samples using the
Illumina GAII platform, generating a total of 184.6 million 65-
nucleotide long paired-end reads (one flow cell lane each for four
sample pools, 12.0 billion bases total, median of 3.7 million reads
per sample). We sequenced 96 serum samples (pool five) on a
HiSeq 2000 instrument, which provides more, longer sequences
per run. The HiSeq run generated 196.4 million 97-nt sequences
(one flow cell lane, 19 billion bases total; median of 1.7 million
reads per sample).
The raw reads were first separated by barcode and analyzed as
individual data sets as described in the Methods. The bioinfor-
matic filtering process consisted of removing low complexity and
low quality sequences, then filtering sequences of human origin
(Figure 1). After the filtering steps, an average of 1.9% of the initial
reads remained, with an absolute average of 60,000 reads
remaining per sample (Figure 1 and Table 1). A few of the
barcode datasets appeared to have a larger non-human fraction.
Upon further inspection, the non-human components were
accounted for by known library preparation contaminants, such
as E. coli and S. cerevisiae.
Detection of Known and Divergent Viruses
The reads remaining after filtering were then compared to
sequences in the NCBI non-redundant nucleotide and protein
databases using BLASTn and BLASTx respectively. Virus-derived
sequences were detected in all 7 positive control samples and in
45/123 (37%) of previously negative serum samples (Table 1). In
78/123 (63%) samples, we were unable to identify virus sequence
by our detection criteria (Methods).
We recovered virus sequences matching the expected viral
genomes in all of the positive control samples. The fraction of viral
sequences in the controls spanned 4 orders of magnitude, from
0.002% to 2.8% of total reads. The two HAV positive control
samples (#401) were aliquots of the same serum sample and were
processed and analyzed independently. The fraction of viral reads
in the duplicates was within 4-fold (0.4% and 1.2%). This
demonstrates that our library preparation, sequencing, and
bioinformatics pipeline is capable of reproducibly detecting
evidence of clinically relevant infections.
In addition to the controls, two non-control samples contained
evidence of RNA virus sequence. Both samples had reads deriving
from GB Virus C (GBV-C, also known as Hepatitis G Virus) and
were essentially identical to GBV-C database sequences. We
detected no sequences that best aligned to dsRNA viruses or to
retroviruses (except for human endogenous retrovirus and
contaminating MLV RT-derived sequences, see Methods).
Human Herpesvirus 6 (HHV-6) sequence was detected in 13/
123 previously negative samples (10.6%). The HHV-6 positive
samples had an average normalized read count of 145 HHV-6
reads per sample (range: 24–411), representing 0.002% to 0.02%
of the datasets (Table 1), and all of these reads possessed high
sequence identity to the HHV-6B reference genome sequence (gi:
9633069). We generated alignments to the reference genome to
investigate the depth and genomic position of the sequence
coverage across the HHV-6 genome (Figure 2). Although the reads
only constitute a relatively small fraction of each dataset, there is
coverage across the entire genome and over many genes in most of
the HHV-6 positive samples.
In addition to HHV-6, we detected Human Herpesvirus 4
(HHV-4, also known as Epstein Barr Virus) sequences in one
sample. As with HHV-6, The HHV-4 sequences were virtually
identical to previously reported sequences. One sample also
contained reads similar to another dsDNA virus, African Swine
Fever Virus (ASFV), which has been previously detected in human
serum [42]. In this case, the reads best matched ASFV capsid
sequences and were relatively divergent (47–51% amino acid
identity; no similarity to non-ASFV sequences by BLASTx).
Attempts to recover additional ASFV sequence by PCR were
unsuccessful.
We also identified sequences derived from single-stranded DNA
viruses in some samples. In one sample we detected Parvovirus
B19-derived reads with high identity to database sequences.
Sequences related to various members of the Anelloviridae virus
family (TTVs) were detected in 21 (17%) samples. This frequency
of detection is within the range reported previously for human
serum [43,44]. The TTV sequences ranged from 40–97% amino
acid identity to their closest database matches. We did not pursue
these sequences further, because TTVs are known to form a
divergent family of viruses and are commonly detected in
apparently healthy individuals.
Sequences similar to members of the Circoviridae family of
ssDNA viruses were detected in 13/123 samples (10.6%). All of the
sequences aligned to circovirus or circovirus-like replicase protein
sequences. The alignments ranged from 36–84% amino acid
identity, and appeared to derive from the replicase genes from
multiple related species (Table 1). Circovirus-like replicase
sequences have been detected in human stool, animals, and
environmental samples [45–48]. We detected a range of 12 to 205
circovirus-like reads per positive sample (Table 1). The low
sequence coverage prohibited complete genome sequence assem-
bly but informed sequence-specific primer design, from which we
were often able to recover larger continuous regions of the
replicase genes by PCR and Sanger sequencing (GenBank
accessions JF781513, JN837698, and see Table S2).
We termed the extended replicase-like sequences Circovirus-like
NI/2007 1–3 (Cvl-NI 1–3), and compared them to a represen-
tative set of other replicase sequences (Figure 3). The Cvl-NI-1
sequence is most closely related to Circovirus-like virus RW-E (gi:
254688530), a circular single-stranded DNA virus previously
found in reclaimed water samples in Florida [45]. The Cvl-NI-2
sequence is most closely related to a replicase sequence recovered
Sequencing Viruses in Tropical Dengue-like Illness
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Table 1. Summary of viruses identified in this study.
Patient
code
Clinic
virus ID
Virochip
virus ID
Sequencing
virus ID
Virus
TaxIDa
# virus
reads
# initial
reads
Fraction
virus reads
187 DENV-2 DENV-2 Dengue virus 2 11060 4280 1.1E+06 3.9E203
275 DENV-2 DENV-2 Dengue virus 2 11060 1511 1.6E+06 9.7E204
282 DENV-2 DENV-2 Dengue virus 2 11060 699 1.6E+06 4.2E204
266 DENV-2 DENV-2 Dengue virus 2 11060 135749 4.8E+06 2.8E202
274 DENV-1 DENV-1 Dengue virus 1 11053 27 1.2E+06 2.3E205
401b HAV HAV Hepatitis A virus 12092 2164 1.8E+05 1.2E202
401b HAV HAV Hepatitis A virus 12092 4562 1.3E+06 3.5E203
235 - - Human herpesvirus 6 10368 116 5.5E+06 2.1E205
451 - - Human herpesvirus 6 10368 88 2.7E+06 3.2E205
207 - - Human herpesvirus 6 10368 390 9.6E+06 4.1E205
432 - - Human herpesvirus 6 10368 411 3.5E+06 1.2E204
574 - - Human herpesvirus 6 10368 138 3.2E+06 4.4E205
370 - - Human herpesvirus 6 10368 90 3.2E+06 2.9E205
78 - - Human herpesvirus 6 10368 113 1.2E+06 9.8E205
131 - - Human herpesvirus 6 10368 24 1.2E+06 2.0E205
183 - - Human herpesvirus 6 10368 66 3.0E+06 2.2E205
270 - - Human herpesvirus 6 10368 28 1.2E+06 2.4E205
344 - - Human herpesvirus 6 10368 303 1.3E+06 2.2E204
350 - - Human herpesvirus 6 10368 48 3.0E+06 1.6E205
438 - - Human herpesvirus 6 10368 72 4.4E+06 1.6E205
315 - - African swine fever virus 10497 42 1.9E+06 2.2E205
382 - - Human herpesvirus 4 10376 44 9.6E+05 4.6E205
387 - - GB virus C 54290 171 9.0E+06 1.9E205
180 - - GB virus C 54290 42 8.0E+05 5.2E205
161 - - Human parvovirus B19 10798 14 3.0E+06 4.7E206
118 - - Circovirus-like genome RW-E 642255 177 7.4E+06 2.4E205
323 - - Circovirus-like genome RW-E 642255 12 5.0E+06 2.4E206
363 - - Circovirus-like genome RW-E 642255 17 1.9E+06 8.9E206
371 - - Circovirus-like genome RW-E 642255 21 1.6E+06 1.3E205
387 - - Circovirus-like genome RW-E 642255 92 9.0E+06 1.0E205
355 - - Beak and feather disease virus 77856 12 2.1E+06 5.7E206
345 - - Beak and feather disease virus 77856 62 2.2E+06 2.9E205
315 - - Swan circovirus 459957 26 1.9E+06 1.4E205
329 - - Gull circovirus 400121 14 2.2E+06 6.3E206
321 - - Porcine circovirus 1 133704 30 4.6E+06 6.5E206
375 - - Porcine circovirus 1 133704 53 3.8E+06 1.4E205
377 - - Cyclovirus PK5034 742916 81 6.6E+06 1.2E205
322 - - Cyclovirus PK5222 742917 206 3.8E+06 5.5E205
235 - - Torque teno virus 68887 23 5.5E+06 4.2E206
73 - TTV Torque teno midi virus 1 687379 137 6.9E+06 2.0E205
505 - - Torque teno virus 68887 37 6.9E+06 5.3E206
505 - - Small anellovirus 393049 25 6.9E+06 3.6E206
457 - - Torque teno virus 68887 29 1.5E+07 1.9E206
171 - - Torque teno mini virus 2 687370 18 1.2E+06 1.6E205
159 - TTV Torque teno mini virus 5 687373 143 2.6E+06 5.6E205
179 - - Torque teno mini virus 1 687369 17 1.8E+06 9.3E206
193 - - Torque teno mini virus 2 687370 56 1.6E+06 3.6E205
183 - TTV Torque teno mini virus 3 687371 139 3.0E+06 4.6E205
156 - TTV Torque teno midi virus 1 687379 213 2.3E+06 9.1E205
186 - - Torque teno virus 15 687354 1701 2.0E+06 8.3E204
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from bat feces in Yunnan Province, China (gi: 342356307) [48].
The Cvl-NI-3 sequence did not overlap with the other sequences
enough to be included in the phylogenetic analysis, but was most
similar to Circovirus-like CB-A, a circovirus-like genome identified
in a Chesapeake Bay environmental sample (gi: 229562105) [45].
A subset of the positive samples (Table 1) contained sequences
from more than one virus, which may be evidence of co-infection.
Almost all of the cases with multiple viruses involved TTV-derived
sequences along with HHV-6, DENV-2, or circovirus-like
sequences (samples 282, 235, 183, 270, 350, and 377). Two
samples contained circovirus-like sequences with ASFV-like
(sample 315) or GBV-C sequences (sample 387).
Discussion
In this study, we examined the virus diversity in serum samples
from Nicaraguan children with unknown acute febrile illness. We
performed Virochip microarray and deep sequencing analyses on
7 positive control and 123 undiagnosed samples. Both of these
methods succeeded in detecting the expected virus in the positive
control samples. Virochip analysis produced putative viral hits in
10/123 (8%) of the previously negative samples, whereas deep
sequencing revealed virus or virus-like sequences in 45/123 (37%).
This study demonstrates the utility of these metagenomic strategies
to detect virus sequence in multiple human serum samples and is
the first to utilize second-generation sequencing to simultaneously
investigate many cases of acute unknown tropical illness.
Monitoring the emergence and spread of novel human
pathogens in tropical regions is a central public health concern.
Metagenomic analysis enables more systemic viral detection of
both known and novel viral pathogens [42] and can be employed
as diagnostic supplements to pathogen detection as part of public
health monitoring systems and epidemiologic surveys [9–12,15–
17,19,21,23]. Despite the headway, metagenomic virus detection
studies will have to confront several remaining difficulties
concerning diagnostic accuracy. Foremost concerns include
enhancing the sensitivity and specificity of deep sequencing-based
diagnostic methods and re-evaluating the evidence for disease
causality in light of increasingly sensitive nucleic acid detection
and pathogen discovery methods. The former will require
improved strategies to biochemically enrich and computationally
identify viral sequences while reducing host background sequenc-
es. The latter will require a cautious reconsideration of criteria
used to establish causal links between microbes and disease, as well
as extensive case-by-case follow-up studies employing classical
laboratory methods, such as serological analysis and cell culture
amplification. It is important to highlight that observing viral
sequence in sequencing data is insufficient to establish the role of a
virus in disease causality. Like other detection strategies, deep
sequencing will serve to inform secondary tests, including
seroconversion assays, further nucleic acid testing, cell culture
amplification, and additional investigations into plausible disease
mechanisms.
We detected virus sequence at concentrations as low as ,2 in
106 reads. Virus sequence detected in a clinical sample at
vanishingly low copy numbers may reflect several possible host-
microbe scenarios. The sequence detected may be that of a
pathogenic virus capable of causing illness at low copy number or
through indirect effects, a ubiquitous non-disease causing microbe,
a virus outside of its primary replication site, low-level contam-
ination, an artifact of sample collection timing/processing, or
remains of incomplete immune clearance. Additional evidence
must be considered in each case to define the host-microbe
relationship.
In this study, we compared the performance of the Virochip and
deep sequencing for detecting virus sequence in human serum.
The limit of detection of the Virochip was approximately one part
in 105 for the poliovirus controls, for which there are microarray
probes with perfect sequence complementarity (Figure S1). The
sensitivity of deep sequencing is limited by the number of reads
generated per sample, or read depth. In this study, we detected
virus sequences down to two parts per million. Nearly every virus
that was detected on the microarray was also detected by deep
sequencing; additionally, in numerous samples (n = 44), sequenc-
ing revealed viruses not detected by the Virochip (Table 1). There
were two instances where Virochip analysis identified a virus
(TTV) that was not detected by deep sequencing (Table 1). Deep
sequencing, therefore, is a superior method for novel virus
discovery, because it is more sensitive and provides more
conclusive genotypic information than the Virochip. Nevertheless,
Patient
code
Clinic
virus ID
Virochip
virus ID
Sequencing
virus ID
Virus
TaxIDa
# virus
reads
# initial
reads
Fraction
virus reads
282 - TTV Torque teno midi virus 1 687379 61 1.6E+06 3.7E205
335 - - Torque teno virus 68887 47 1.7E+06 2.8E205
330 - - TTV-like mini virus 93678 77 1.8E+06 4.2E205
270 - - Torque teno virus 8 687347 82 1.2E+06 7.1E205
331 - - Torque teno midi virus 2 687380 113 1.4E+06 8.2E205
349 - TTV Torque teno midi virus 432261 47 1.6E+06 2.9E205
350 - TTV Torque teno mini virus 4 687372 51 3.0E+06 1.7E205
566 - TTV Torque teno mini virus 4 687372 206 1.9E+06 1.1E204
377 - - Torque teno mini virus 4 687372 153 6.6E+06 2.3E205
168 TTVc 1.9E+05
263 - TTV 1.5E+06
(a)The NCBI TaxID and name of the virus species with the highest number of hits among those viruses with BLAST hits is given.
(b)These two samples were prepared from aliquots of the same serum sample.
(c)In its deep sequencing dataset, Sample 168 had 9 reads matching TTV, just below our positive identification threshold.
doi:10.1371/journal.pntd.0001485.t001
Table 1. Cont.
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the Virochip is a relatively fast and inexpensive method that is best
applied to samples with expected virus copy numbers present at
levels greater than 1 in 105 host sequences.
We were unable to detect a virus in two thirds of the 123
dengue-like illness samples. These results could reflect true
negative status, which would result from a non-viral infection,
illness due to non-infectious agent, or complete immunologic
clearance. Alternatively, the negative results could reflect failures
in our diagnostic approaches due to imperfect sensitivity,
unsatisfactory sample preparation, improper sample type, or
failure to recognize highly divergent viral sequences. The presence
of sequences that lack even remote similarities to known species
also highlights the need for further development of de novo assembly
methods for metagenomic data. Assembled data, increased depth,
and enhanced sequenced comparison methods should enable
more sensitive detection of divergent viruses in metagenomic
samples.
Determining the etiology of human diseases with symptoms that
overlap with dengue-like illness is important for understanding the
full spectrum of emerging or previously uncharacterized pathogens
in tropical populations. In this study, 10% of acute serum samples
negative for dengue virus from cases of pediatric dengue-like illness
were positive for HHV-6. Primary HHV-6 infection causes
undifferentiated febrile illness and exanthem subitum (roseola infantum
or sixth disease), an acute illness with high fever and rash that
typically resolves in three to seven days [49]. Exanthem subitum is a
common disease of infants worldwide, and HHV-6 infection most
frequently occurs between 6 and 12 months of age [50], with
seropositivity estimates of .95% in adult populations in developed
countries [51]. The HHV-6 positive patients in this study were
between 7–12 months old, and presented with fever and rash
(Table S3). We detected multiple kilobases of HHV-6 sequence in
each positive sample, with sequence deriving from multiple viral
genomic regions (Figure 2).
After acute infection, HHV-6 can latently persist in the host
quiescently, with no production of infectious virions or with low
levels of viral replication. Latency is believed to endure in several
cell types, including monocytes and bone marrow progenitor cells
[52,53], and may undergo chromosomal integration that can be
vertically transmitted [54]. The confounding effects of chromo-
somal integration make differentiating between active and latent
HHV-6 infections difficult when detecting HHV-6 sequence in
Figure 1. Bioinformatic filtering of deep sequencing data. Average percent remaining reads after each of the filtering steps. Low-quality and
low-complexity reads are removed first, followed by iterative BLAT and BLAST comparisons to human sequence. Averages were calculated for all
samples (n = 130). Inset: secondary pipeline depicting post-filtering viral searches. The dashed bubble includes future methods to improve the
sensitivity of viral sequence detection.
doi:10.1371/journal.pntd.0001485.g001
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serum DNA [55,56]. A previous study detected integrated HHV-6
genomic sequence in ,1% of healthy blood samples [57]. Since
detection of HHV-6 nucleic acid in serum alone does not prove
active viral infection, we cannot definitively confirm that the
HHV-6 sequences in these samples were not derived from the
vertical transmission of chromosomally integrated virus. However,
the clinical, epidemiological, and virus sequence data suggest
HHV-6 may be the etiologic agent in these febrile illness cases.
Primary HHV-6 infection is a major cause (,20%) of infant
hospitalizations in the United States [58], a clinical burden likely
shared throughout the tropical world given similar seroprevalence
rates [59]. The results of this study illustrate the importance of
administering HHV-6 diagnostic tests to cases of suspected
dengue-like illness in infants from dengue-endemic regions to
differentiate between cases of exanthem subitum, a ubiquitous self-
limiting childhood illness, and dengue fever, which carries a
greater risk of severe clinical complications and death.
Similarly, the one sample positive for Parvovirus B19 sequence
may be a case of acute infection with a commonly acquired
childhood virus. Parvovirus B19 can manifest as erythema infectiosum
(fifth disease), a condition associated with characteristic ‘‘slapped
cheek’’ rash [60]. Infection can also be subclinical or result in mild
nonspecific symptoms. It is possible that Parvovirus B19 infection
caused the symptoms in this case (Table S3), though as with HHV-
6, the identification of viral sequences does not definitively
demonstrate causality.
Figure 2. HHV-6B genome coverage in positive samples. Histograms of HHV-6B genome coverage generated by aligning reads with minimum
90% identity over the total read length to the genome. The depth of sequence coverage was calculated as the total Kb of aligned sequence per 1 Kb
bin over the HHV-6B reference genome. Genome track representation adapted from Dominguez et al [65]. The blue box represents conserved genes
across the betaherpesvirus subfamily, the orange boxes represent core genes across the herpesvirus family, the green box represents the late
structural genes (gp82-105), and the asterisk denotes the origin of lytic gene replication. Inset text for each histogram is the sample code. Coverage is
shown for samples with greater than 80 HHV-6 reads.
doi:10.1371/journal.pntd.0001485.g002
Sequencing Viruses in Tropical Dengue-like Illness
www.plosntds.org 8 February 2012 | Volume 6 | Issue 2 | e1485
Epstein Barr Virus (HHV-4) sequences were found in the serum
of one patient who presented with relatively severe symptoms, and
died during hospitalization (Table S3). HHV-4 infection is a nearly
universal occurrence in the first two decades of life [61,62].
Primary infection in adolescents or adults can manifest as
infectious mononucleosis, and chronic infection is associated with
various malignancies later in life. Primary infection during
childhood, however, is usually asymptomatic or produces only
mild symptoms. It is not clear that HHV-4 infection or HHV-4
alone caused the illness in this case.
In addition to the viruses for which a plausible disease
association exists, many samples contained sequences from viruses
with no well-established link to human disease. These included the
two samples positive for GBV-C and those containing ASFV-like,
TTV-like, and circovirus-like sequences.
The Circoviridae family is an extraordinarily diverse group of
small, single-stranded circular DNA viruses that includes cyclo-
viruses (genus Cyclovirus) and circoviruses (genus Circovirus), which
are commonly detected in human stool and blood, and also in
environmental samples [43–48]. Some circovirus species, such as
beak and feather disease virus and porcine circovirus 2, have been
associated with disease in bird and pig hosts, respectively, but the
pathogenic potential of circoviruses in humans remains uncon-
firmed [63,64]. The circovirus-like sequences reported here were
detected in nucleic acid libraries prepared from acute human
serum and were most closely related to circovirus-like viruses
(Figure 3), which were first reported in environmental samples and
in bats [45,48]. We were unsuccessful in recovering a full genome
sequence corresponding to any of the circovirus-like sequences,
and it has not yet been possible to prove that these sequences were
not an environmental artifact introduced during sample prepara-
tion. It is also possible that these sequences derive from other
organisms, such as Giardia intestinalis or Entamoeba dispar, whose
genomes encode proteins that share amino acid similarity with
circovirus replicase proteins (Figure 3). Furthermore, it has yet to
be established whether circoviruses are capable of replicating in
humans. Pending additional screening and serologic studies, the
detection of circovirus-like sequences from human serum should
be interpreted with caution.
Metagenomic approaches provide an effective high-through-
put method to detect uncharacterized virus diversity in a tropical
setting from many samples simultaneously. The findings
presented in this study further our knowledge of well-character-
ized and previously unknown viruses present in serum collected
from pediatric dengue-like illness patients and advance our
understanding of the application of metagenomic approaches to
human pathogen detection. Deep sequencing analysis of clinical
samples holds tremendous promise as a diagnostic tool by
permitting the detection of many different viruses simultaneous-
ly, including those present at low-copy numbers and of divergent
origin. Major remaining barriers to high-throughput sequencing
strategies becoming standard diagnostic practice include prohib-
itive cost, lengthy sample preparation time, and computationally
intensive data analysis requirements. These challenges are
magnified in resource-limited settings, such as Nicaragua, but
are gradually being addressed. Industry hardware and technical
advancements have steadily decreased the per-base cost of deep
sequencing, and the results presented here strengthen our
expectations of multiplexed sample preparation and bioinfor-
matic data filtering within the framework of current second-
generation sequencing platforms. Long-term bi-directional
partnerships with developing country collaborators facilitate
easier access to techniques not currently available on-site, such as
deep sequencing, and are also important in providing training
opportunities for local scientists and developing relevant
pathogen tests and diagnostic policies.
Figure 3. Circovirus-like NI sequence coverage and phylogeny. Phylogenetic neighbor-joining tree of amino acid sequences showing the
relationship between Circovirus-like NI rep sequences (red) and 19 representative replicase sequences. Abbreviations: CV, circovirus, Ba, Barbel, Bat,
Bat ZS/Yunnan-China/2009, BFDV, beak and feather disease virus, Ca, Canary Circo-like Circovirus-like genome, Cyclo, cyclovirus, PKbeef, PKbeef23/
PAK/2009, Du, Muscovy duck, Ed, Entamoeba dispar, Gi, Giardia intestinalis, PCV2, Porcine circovirus 2, RodCV, Rodent stool-associated circular
genome virus, UncCV, uncultured circovirus. For a full list of sequences and accession numbers, see Table S2.
doi:10.1371/journal.pntd.0001485.g003
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This study expands our understanding of the virus diversity in
pediatric dengue-like illness in Nicaragua and the application of
genomic detection techniques in a tropical setting, findings that are
particularly valuable given the pressing need for improved global
emerging pathogen surveillance.
Supporting Information
Figure S1 Virochip sensitivity using poliovirus control
RNA. The Virochip can detect one poliovirus gRNA in a
background of 105 HeLa RNA molecules. Poliovirus RNA was
mixed with HeLa total RNA and analyzed on the Virochip. Eighty
enterovirus Virochip oligos were found to be responsive to the
poliovirus RNA and the mean fold above background of the
normalized intensity of these oligos is plotted. Background is
defined as the normalized intensity for each oligo in the HeLa-only
control sample. The top E-predict hit in the 1025 to 1022 samples
was human enterovirus C.
(PDF)
Table S1 This table lists the sequences of the oligonu-
cleotides used in this study.
(PDF)
Table S2 This table lists the accession numbers of
protein sequences used to construct the phylogenetic
tree in Figure 3.
(PDF)
Table S3 This table displays the clinical signs recorded
during hospitalization.
(PDF)
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